Stan Blein is an accomplished scientist with a robust background in structural biology, immunology, and antibody engineering. Starting as a Post Doctoral Fellow at The University of Edinburgh, Stan's career progressed through various leadership roles at notable organizations such as GSK-Domantis Ltd, Glenmark Pharmaceuticals, and Ichnos Sciences, leading initiatives in therapeutic domain antibodies and drug portfolio progression. Currently serving as Senior Director at AstraZeneca, Stan heads Protein Sciences and Tumor Targeted Delivery, driving innovation in biotherapeutics. With a PhD in Structural Biology from The University of Edinburgh and a management certificate from Ecole polytechnique fédérale de Lausanne, Stan has contributed significantly to the field through numerous patented technologies and has led various successful projects in clinical development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices